Adherence to treatment of patients with past ischemic stroke.

Authors

  • V. Je. Azarenko
  • V. A. Potabashniy
  • V. I. Fesenko
  • O. V. Knjazjeva

DOI:

https://doi.org/10.26641/2307-0404.2018.1(part2).126931

Keywords:

consequences of ischemic stroke, general practice-family medicine, Morissky-Green scale, secondary prevention, adherence to treatment

Abstract

The main task of the general practitioner is managing patients with the effects of ischemic stroke. The improvement of patients adherence to treatment in a significant way contributes to successful secondary prevention of ischemic stroke. Adherence to treatment can be determined through various questionnaires, including Morissky-Green. Currently, the adherence to a long-term drug therapy remains insufficient.

Author Biographies

V. Je. Azarenko

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of therapy, cardiology and family medicine of FPE
Аrea 30-rіchchja Peremogi, 2, Kryvyi Rig, Dnipropetrovsk region, 50000, Ukraine

V. A. Potabashniy

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of therapy, cardiology and family medicine of FPE
Аrea 30-rіchchja Peremogi, 2, Kryvyi Rig, Dnipropetrovsk region, 50000, Ukraine

V. I. Fesenko

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of therapy, cardiology and family medicine of FPE
Аrea 30-rіchchja Peremogi, 2, Kryvyi Rig, Dnipropetrovsk region, 50000, Ukraine

O. V. Knjazjeva

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of therapy, cardiology and family medicine of FPE
Аrea 30-rіchchja Peremogi, 2, Kryvyi Rig, Dnipropetrovsk region, 50000, Ukraine

References

Kovalenko VM, Kornac'kyj VM. [Diseases of the circulatory systemas a medical and social and socio-po­li­tical problem]. Analitychno-statystychnyjposibnyk. Кyiv. 2014;279. Ukrainian.

Lukina JuV, Marcevich SJu, Kutishenko NP. [Morissky-Greene scale: the pros and cons of universal test, work on mistakes]. Racional'naja farmakoterapija v kardiologii. 2016;12(1):63-65. Russian.

Radchenko GD, Sirenko JuM, Martsovenko ІM. [Adherence to the treatment of patients with arterial hy­pertension and its changes on the background of therapy. Results of open prospective multicenter study]. Uk­rai'n­s'kyj kardiologichnyj zhurnal. 2010;3:44-57. Ukrainian.

Suslina ZA, Fonjakin AV,Geraskina LA.[Ische­mic stroke and heart: from pathogenesis to prevention]. Klinich. farmakol. i terapija. 2003;5:47-51. Russian.

Shandalin VA, Fonjakin AV,Geraskina LA.[Se­condary prevention of ischemic stroke: from recom­mendations to real clinical practice]. Zhurnal nevrologii, nejropsihiatrii i psihosomatiki. 2012;2:35-41. Russian.

Chobian AV. The Hypertension Paradox – more uncontrolled disease despite improved therapy. N. Engl. J. Med. 2009;361(15):15-16.

Global Burden of Disease Study 2016 (GBD 2016) Data Resources. Available from: ghdx.health­data.org/gbd-2016.

Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack. A guideline for healthсare pro­fessionals from the American heart association. American stroke association. Stroke. 2011;42:227-76.

Jamison J, et al. Barriers and facilitators to adhe­rence to secondary stroke prevention medications afters troke: analysis of survivors and caregivers views from an online stroke forum. BMJ Open 2017;7:e016814. doi: 10.1136/bmjopen-2017-01681

Haynes RB, Teylor DW, Sackett DL. Compliance in healthcare. Baltimor: TheJohnsHopkinsUniversityPress; 1979.

Jamison J, Graffy J, Mullis R, MantJ, Sutton S. Barriers to medication adherence for the secondary pre­vention of stroke: a qualitative interview study in primary care. Br J Gen Pract. 2016;66(649):e568-76. Published online 2016 May 24. doi: 10.3399/bjgp16X685609

Lago A,·Tembl JI,·Pareja A, Ponz A,·Ferrer JM, Vallés J, Santos MT. Adherence to aspirin in secondary prevention of ischemic stroke. Cerebrovasc Dis 2006;21:353-6. https://doi.org/10.1159/000091542

Kulkarni SP, Alexander KP, Lytleetal B. Long-Term adherence with cardiovascular drug regimens. Am. Heart J. 2006;151(1):185-91.

MoriskyDE, Ang A, Krousel-Wood M, Harry J. Ward. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348-54.

Sabate E. Adherence to long-term therapies: evi­dence for action.Geneva: WHO; 2003.

Simpson E, Eurich DT, Majumdaretal SR. A meta-analysis of the association between adherence to drugtherapy and mortality. BMJ. 2006;333:15.

How to Cite

1.
Azarenko VJ, Potabashniy VA, Fesenko VI, Knjazjeva OV. Adherence to treatment of patients with past ischemic stroke. Med. perspekt. [Internet]. 2018May4 [cited 2021Sep.25];23(1(part2):11-4. Available from: http://journals.uran.ua/index.php/2307-0404/article/view/126931

Issue

Section

CLINICAL MEDICINE

Most read articles by the same author(s)